Mary McNamara-Cullinane
General Counsel at CLEARPOINT NEURO, INC.
Profile
Mary McNamara-Cullinane is currently the Vice President-Regulatory Affairs at Clearpoint Neuro, Inc. She previously worked as the Director-Regulatory Affairs & Quality Assurance at Molecular Biometrics, Inc. and as the Vice President-Regulatory & Clinical Affairs at Echo Therapeutics, Inc. Ms. McNamara-Cullinane obtained an undergraduate degree from Massachusetts College of Liberal Arts.
Mary McNamara-Cullinane active positions
| Companies | Position | Start |
|---|---|---|
| CLEARPOINT NEURO, INC. | General Counsel | 2022-08-07 |
Former positions of Mary McNamara-Cullinane
| Companies | Position | End |
|---|---|---|
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | General Counsel | - |
| ECHO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Mary McNamara-Cullinane
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CLEARPOINT NEURO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Commercial Services |
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
- Stock Market
- Insiders
- Mary McNamara-Cullinane
